Skip to Content
  • Review
  • Open Access

26 September 2025

20 Pages

Navigating the Central Nervous System (CNS): A Pharmacokinetic Approach to the Treatment of CNS Tumors, Glioblastoma Multiforme (GBM), in Particular

,
,
,
and
1
Department of Biochemistry and General Chemistry, Medical Faculty, Collegium Medicum, Rzeszów University, 35-310 Rzeszów, Poland
2
English Division Science Club, Medical Faculty, Collegium Medicum, Rzeszów University, 35-310 Rzeszów, Poland
3
Specialist Hospital in Tarnów, 33-100 Tarnów, Poland
4
Department of Photomedicine and Physical Chemistry, Medical Faculty, Collegium Medicum, Rzeszów University, 35-310 Rzeszów, Poland
This article belongs to the Section Molecular Neurobiology

Abstract

Tumors of the central nervous system (CNS) represent a unique therapeutic challenge due to the complexity of the CNS and the protective role of the blood–brain barrier (BBB). All gliomas are of glial origin, account for the majority of CNS tumors, and are classified by the World Health Organization into four grades based on malignancy. High-grade gliomas, such as glioblastoma multiforme (GBM), exhibit aggressive growth, resistance to treatment, and poor prognosis. Despite significant advancements in cancer therapy, effective drug delivery to CNS tumors remains limited due to pharmacokinetic barriers, especially the BBB, and tumor-related resistance mechanisms. This review highlights the biological characteristics of gliomas and emphasizes the current challenges in achieving effective CNS tumor treatment.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.